at Zacks.com (Dec 22, 2014)
Genomic Health Inc (GHDX): Q4 EPS of $0.08 misses by $0.01. Revenue of $53.4M (+13.4% Y/Y) in-line. (PR)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
Genomic Health, Inc. (GHDX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Reportat Zacks.com (Dec 18, 2014)
at Zacks.com (Dec 17, 2014)
at Zacks.com (Dec 16, 2014)
at Zacks.com (Dec 11, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs